Stage IIIA Skin Melanoma Active Not Recruiting Phase 2 Trials for DB00493 (Cefotaxime)

IndicationStatusPhase
DBCOND0029533 (Stage IIIA Skin Melanoma)Active Not Recruiting2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01807182Tumor-Infiltrating Lymphocytes After Combination Chemotherapy in Treating Patients With Metastatic MelanomaTreatment